| Literature DB >> 17009221 |
C Aquino-Parsons1, J Hukin, A Green.
Abstract
In an attempt to improve local control, we assessed the feasibility of the addition of 4 min of carbogen inhalation (as a radiosensitizer) to daily fractionated radiotherapy in pediatric patients with high grade and/or diffuse brainstem gliomas. Ten patients inhaled carbogen for >90% of the radiation treatments. Median survival time from start of therapy was 0.80 years. Carbogen inhalation did not appear to improve the dismal prognosis. (c) 2007 Wiley-Liss, Inc.Entities:
Mesh:
Substances:
Year: 2008 PMID: 17009221 DOI: 10.1002/pbc.21057
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167